How is enzalutamide used to ensure therapeutic efficacy?
Enzalutamide (Enzalutamide) is an anti-androgen drug used to treat prostate cancer. It mainly inhibits the activity of androgen receptors and reduces the stimulation of androgen to cancer cells, thereby controlling the development of cancer. To ensure therapeutic effectiveness, patients need to follow specific dosage, usage, and precautions when using enzalutamide.
First of all, the standard usage of enzalutamide is 160mg once a day, which usually requires long-term use. Patients should strictly adhere to the dosage according to the doctor's instructions and do not adjust the dosage or discontinue the medication on their own. Enzalutamide should be taken by mouth, preferably with food to improve absorption of the drug. Patients need regular medical tests, such as blood tests and imaging tests, to monitor treatment effects and drug tolerance.

Secondly, in order to ensure the therapeutic effect, patients need to pay attention to some possible side effects while taking enzalutamide. Common side effects of enzalutamide include fatigue, headache, joint pain, hot flashes, and gastrointestinal upset. If more serious side effects occur, such as seizures, abnormal liver function, or heart problems, you should stop taking the medicine immediately and contact your doctor. Regular monitoring and timely management of side effects help ensure the safety and effectiveness of drug treatments.
In addition, patients need to regularly monitor prostate-specific antigen (PSA) levels under the guidance of a doctor to evaluate the effect of treatment. As treatment progresses, doctors will adjust the treatment plan based on the patient's response to ensure continued effectiveness of the treatment. Enzalutamide has significant efficacy in patients with metastatic castration-resistant prostate cancer (mCRPC), especially for those who have received chemotherapy and other anti-cancer treatments. Enzalutamide can significantly prolong progression-free survival.
Reference materials:https://www.xtandi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)